About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6605 record(s)
Req # A-2018-001052
All Electronic documents that pertain to Essure Permanent Birth Control System.Organization: Health Canada
November 2023
Req # A-2020-000373
All briefing notes and related materials given to Minister Hajdu related to the coronavirus, Covid 19 in May.Organization: Health Canada
November 2023
Req # A-2020-000554
Concerning your access to information statistical report for fiscal year 2018/19 https://www.canada.ca/content/dam/tbs-sct/documents/access-information-privacy/2018-19-ati-eng.csv, please provide: the file number; in relation to the item, the date…Organization: Health Canada
November 2023
Req # A-2020-000672
All records concerning the refusal of Chinese officials to ship the CanSino Biologics Ad5-nCoV vaccine to Canada and the abandonment of the testing program. Time period: May 1, 2020 to September 1, 2020.Organization: Health Canada
November 2023
Req # A-2021-000082
Requesting 100 written submissions received by Health Canada in response to the online engagement on a National Strategy for High Cost Drugs for Rare diseases which ran from January 27, 2021 to March 26, 2021.Organization: Health Canada
November 2023
Req # A-2022-000164
In the Memorandum of Understanding (MOU) signed by the federal government and provinces and territories (P/T's) that governs the blood system - section 5.4, - Health Canada is obliged to provide annual reports to Canadian Biosafety Standard (…Organization: Health Canada
November 2023
Req # A-2022-000823
All communications with representatives of Twitter, regarding the potential or actual removal of content described as “misinformation”, “disinformation”, “harmful”, "false", "conspiracy", "anti-vax", "anti-…Organization: Health Canada
November 2023
Req # A-2022-001233
All records between September 20, 2020 to December 31, 2020 which make any reference to the changes that were made to the noted webpage. https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-…Organization: Health Canada
November 2023
Req # A-2022-001514
Health Canada has recently signed an agreement with British Columbia (BC) for health data sharing. Provide copy of agreement signed between Feb 1, 2023 and March 2, 2023 between Health Canada and the province of BC. Provide the agreement definition…Organization: Health Canada
November 2023
Req # A-2023-000016
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-03-24 for the medicinal ingredient Doxorubicin.…Organization: Health Canada
November 2023